Cargando…
β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin
In recent years, thyrotropin-releasing hormone (TRH) and its analogs, including taltirelin (TAL), have demonstrated a range of effects on the central nervous system that represent potential therapeutic agents for the treatment of various neurological disorders, including neurodegenerative diseases....
Autores principales: | Drastichova, Zdenka, Trubacova, Radka, Novotny, Jiri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103620/ https://www.ncbi.nlm.nih.gov/pubmed/35563779 http://dx.doi.org/10.3390/cells11091473 |
Ejemplares similares
-
Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012) -
Biochemical and physiological insights into TRH receptor-mediated signaling
por: Trubacova, Radka, et al.
Publicado: (2022) -
Differential activating effects of thyrotropin-releasing hormone and its analog taltirelin on motor output to the tongue musculature in vivo
por: Liu, Wen-Ying, et al.
Publicado: (2020) -
Are thyrotropin‐releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid‐induced respiratory depression?
por: Algera, Marieke Hyke, et al.
Publicado: (2022) -
Proteomic Analysis Unveils Expressional Changes in Cytoskeleton- and Synaptic Plasticity-Associated Proteins in Rat Brain Six Months after Withdrawal from Morphine
por: Drastichova, Zdenka, et al.
Publicado: (2021)